Hospira To Pay $60M To Settle Shareholder Class Action
Global pharmaceutical company Hospira Inc. agreed to pay $60 million on Thursday to settle a class action lawsuit accusing it of violating securities laws by providing misleading positive statements that artificially...To view the full article, register now.
Already a subscriber? Click here to view full article